Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

Yuliang Xiang,Yingyao Chen,Zian Xu,Shanyan Zhou,Zhiyong Qin,Lingchao Chen,Dunming Xiao,Shimeng Liu
DOI: https://doi.org/10.1007/s11060-024-04662-x
2024-04-03
Journal of Neuro-Oncology
Abstract:Glioblastoma (GBM) stands as the most aggressive and prevalent primary brain malignancy. Tumor Treating Fields (TTFields), an innovative therapy complementing chemotherapy for GBM treatment, which can significantly enhance overall survival, disease progression-free survival, and patient's quality of life. However, there is a dearth of health economics evaluation on TTFields therapy both domestically and internationally.
oncology,clinical neurology
What problem does this paper attempt to address?